Clinical trial
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)
NCT04706273 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)
- Lead sponsor
- W.L.Gore & Associates
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 25, 2016
- Completion date
- December 14, 2022
- Enrollment
- 321 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.